In Brief: Collagen
This article was originally published in The Gray Sheet
Collagen: Plans to spin off its Collagen Technologies R&D business to Collagen shareholders by spring 1998, David Foster, senior VP and general manager of Collagen Technologies Group, stated at an Oct. 27 session of the Oppenheimer conference. Collagen announced plans to separate the operations from Collagen's Aesthetic Technologies businesses in January ("The Gray Sheet" Jan. 13, I&W-4)...
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.